How do I choose between different analytical development labs for oral, injectable, and specialty dosage forms?

Choosing the right analytical development lab depends on what dosage form you have, what stage you’re in, and what expertise/equipment the lab needs to have. Oral solid, injectable, and specialty dosage forms can look similar on paper but often require very different analytical capabilities.

1) Start with the dosage form

Oral dosage forms

Examples: tablets, capsules, granules, suspensions, oral liquids.

Look for a lab with strength in:

• Assay and impurities by HPLC/UPLC
• Dissolution and disintegration
• Content uniformity / blend uniformity
• Particle size analysis if relevant
• Stability-indicating methods
• Extractables/leachables if packaging is important
• Microbiology for oral liquids, suspensions, or non-sterile products if needed

Injectable dosage forms

Examples: sterile solutions, suspensions, lyophilized powders, biologics, liposomes, emulsions.

Look for a lab with stronger sterile and parenteral capabilities:

• Sterility-related method development and sterile sample handling
• Endotoxin / pyrogen testing
• Particulate matter testing
• pH, osmolality, appearance
• Container closure integrity support
• Lyophilization cycle-related analytics if applicable
• Low-level impurity detection
• Extractables/leachables
• Strong cleanroom and contamination control practices

Specialty dosage forms

Examples: transdermal, inhalation, ophthalmic, nasal, topical, depot injections, implants, drug-device combinations.

These often need very specific expertise:

• Aerosol performance / particle deposition for inhalation
• Permeation and release testing for transdermals/topicals
• Rheology and viscosity
• In vitro release testing (IVRT) / in vitro permeation testing (IVPT)
• Device compatibility and combination-product support
• Advanced characterization for complex formulations
• Experience with non-standard methods and regulatory strategy

2) Match the lab to your development stage

Early development / preformulation

Prioritize:

• Fast method development
• Analytical problem-solving
• Material characterization
• Flexibility with limited sample amounts

Late development / validation / filing

Prioritize:

• cGMP readiness
• Method validation experience
• Data integrity
• Regulatory documentation
• Robust QA systems
• Experience supporting IND/CTA, NDA/ANDA, BLA, MAA

Post-approval / lifecycle

Prioritize:

• Change control support
• Comparability studies
• Stability program management
• Method transfer success
• Ongoing troubleshooting

3) Evaluate technical fit

Ask whether they can handle:

• Your API chemistry and degradation pathways
• Your matrix complexity: simple solution vs suspension vs semisolid vs sterile complex formulation
• Required instrumentation:
  • HPLC/UPLC, GC, LC-MS/MS, ICP-MS
  • Dissolution, particle sizing, Karl Fischer, DSC/TGA, rheology
  • Microbiology/sterility/endotoxin systems
• Sample throughput and turnaround time
• Ability to develop stability-indicating methods
• Experience with reference standards and impurity identification

4) Check quality and compliance

A good analytical development lab should have:

• cGMP or GLP capability, as needed
• Strong QA oversight
• Data integrity controls
• Audit history and regulatory inspection readiness
• SOPs for method development, validation, and transfer
• Electronic systems with audit trails
• Experience with ICH, USP, EP, JP, and other relevant standards

5) Assess communication and method-transfer capability

Even a technically strong lab may fail you if they are poor at collaboration.

Look for:

• Clear project management
• Frequent technical updates
• Good documentation
• Willingness to explain decisions and assumptions
• Successful method transfer to QC or another site
• Ability to write defensible protocols and reports

6) Ask the right questions

Here are practical questions to use in vendor selection:

General

• What dosage forms have you supported most often?
• What is your experience with products like ours?
• Can you show examples of similar projects or regulatory submissions?
• What are your typical timelines for method development and validation?

Oral

• How do you handle dissolution method development for difficult products?
• Do you have experience with modified-release products or low-dose compounds?

Injectables

• What sterile handling and contamination controls do you use?
• Do you support endotoxin, particulate, and CCI testing?
• Have you worked with lyophilized products or complex parenterals?

Specialty dosage forms

• Do you have specialized equipment for inhalation, transdermal, ophthalmic, or semisolid testing?
• Have you developed IVRT/IVPT or aerosol performance methods?
• How do you handle combination products and device-related testing?

7) Make a weighted decision

A simple scoring approach helps:

• Technical expertise – 40%
• Regulatory/quality readiness – 25%
• Turnaround time and capacity – 15%
• Communication and project management – 10%
• Cost – 10%

For injectables and specialty dosage forms, you may want to give technical fit and quality even more weight than cost.

8) Practical rule of thumb

• Choose a general analytical development lab for straightforward oral products and early screening.
• Choose a sterile/parenteral-specialized lab for injectables.
• Choose a niche specialty lab for inhalation, transdermal, ophthalmic, topical, or combination products.
• If your product is complex, use a lab with documented experience in your exact dosage form, even if they cost more.

9) Red flags

Be cautious if a lab:

• Says they can do everything but has little dosage-form-specific experience
• Lacks QA or validation documentation
• Has vague answers about method robustness or transfer
• Cannot describe prior regulatory support
• Has poor contamination-control practices for sterile products
• Doesn’t ask enough questions about your formulation and intended use

If you want, I can also give you:

1. a vendor scorecard template, or
2. a decision matrix specifically for oral vs injectable vs specialty dosage forms.